<!doctype html> <html> <head><style>
             table { border-collapse: collapse; }
             th, td {
               word-wrap: break-word;
               max-width: 100%;
               font-family: "Trebuchet MS", Arial, Helvetica, sans-serif;
               border-bottom: 1px solid #ddd;
               padding: 5px;
               text-align: left;
             }
            tr:hover {background: #f4f4f4;}
            tr:hover .highlighted {background: repeating-linear-gradient(
                    45deg,
                    #ffff99,
                    #ffff99 10px,
                    #f4f4f4 10px,
                    #f4f4f4 20px
                  );}
           .highlighted { background-color: #ffff99; }
          </style></head><body><h2>List of Schedule I drugs (US)</h2><br> <b>Section Title</b>: Temporary/emergency listings <br><b>Table Section Text</b>: These items are listed by the Secretary of Health and Human Services pursuant to 21 CFR 1308.49. <br> <table>
<tr> <th colspan=1 rowspan=1 > ACSCN </th><th colspan=1 rowspan=1 > Drug </th></tr>
<tr> <td colspan=1 rowspan=1 > 7144 </td><td colspan=1 rowspan=1 > (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone, its optical, positional, and geometric isomers, salts and salts of isomers (UR-144, 1-pentyl-3-(2,2,3,3-tetramethylcyclopropoyl)indole) </td></tr>
<tr> <td colspan=1 rowspan=1 > 7011 </td><td colspan=1 rowspan=1 > [1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone, its optical, positional, and geometric isomers, salts and salts of isomers (5-fluoro-UR-144, 5-F-UR-144, XLR-11, 1-(5-fluoro-pentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)indole) </td></tr>
<tr> <td colspan=1 rowspan=1 > 7048 </td><td colspan=1 rowspan=1 > N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers (APINACA, AKB-48) </td></tr>
<tr> <td colspan=1 rowspan=1 > 7222 </td><td colspan=1 rowspan=1 > Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (QUPIC, PB-22) </td></tr>
<tr> <td colspan=1 rowspan=1 > 7225 </td><td colspan=1 rowspan=1 > Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22) </td></tr>
<tr> <td colspan=1 rowspan=1 > 7012 </td><td colspan=1 rowspan=1 > N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) </td></tr>
<tr> <td colspan=1 rowspan=1 > 7035 </td><td colspan=1 rowspan=1 > N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA) </td></tr>
<tr> <td colspan=1 rowspan=1 > 7031 </td><td colspan=1 rowspan=1 > N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) </td></tr>
<tr> <td colspan=1 rowspan=1 > 7023 </td><td colspan=1 rowspan=1 > N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) </td></tr>
<tr> <td colspan=1 rowspan=1 > 7024 </td><td colspan=1 rowspan=1 > [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201) </td></tr>
<tr> <td colspan=1 rowspan=1 > 7538 </td><td colspan=1 rowspan=1 > 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5) </td></tr>
<tr> <td colspan=1 rowspan=1 > 7537 </td><td colspan=1 rowspan=1 > 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82) </td></tr>
<tr> <td colspan=1 rowspan=1 > 7536 </td><td colspan=1 rowspan=1 > 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36) </td></tr>
<tr> <td colspan=1 rowspan=1 > 9547 </td><td colspan=1 rowspan=1 > 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]N-methylbenzamide) (U-47700) </td></tr>
<tr> <td colspan=1 rowspan=1 > 9821 </td><td colspan=1 rowspan=1 > Acetylfentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) </td></tr>
<tr> <td colspan=1 rowspan=1 > 9834 </td><td colspan=1 rowspan=1 > N-(1-Phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide (furanyl fentanyl) </td></tr>
<tr> <td colspan=1 rowspan=1 > 7034 </td><td colspan=1 rowspan=1 > 2-(1-(5-Fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (5F-ADB, 5F-MDMB-PINACA) </td></tr>
<tr> <td colspan=1 rowspan=1 > 7033 </td><td colspan=1 rowspan=1 > Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (5F-AMB) </td></tr>
<tr> <td colspan=1 rowspan=1 > 7049 </td><td colspan=1 rowspan=1 > N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (5F-APINACA, 5F-AKB48) </td></tr>
<tr> <td colspan=1 rowspan=1 > 7010 </td><td colspan=1 rowspan=1 > N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (ADB-FUBINACA) </td></tr>
<tr> <td colspan=1 rowspan=1 > 7042 </td><td colspan=1 rowspan=1 > Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (MDMB-CHMICA, MMB-CHMINACA) </td></tr>
<tr> <td colspan=1 rowspan=1 > 7020 </td><td colspan=1 rowspan=1 > Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (MDMB-FUBINACA) </td></tr>
<tr> <td colspan=1 rowspan=1 > 9811 </td><td colspan=1 rowspan=1 > Acryl fentanyl ((N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide); Acryloylfentanyl) </td></tr>
<tr> <td colspan=1 rowspan=1 > 9816 </td><td colspan=1 rowspan=1 > N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (Ortho-fluorofentanyl or 2-fluorofentanyl) </td></tr>
<tr> <td colspan=1 rowspan=1 > 9822 </td><td colspan=1 rowspan=1 > Butyryl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) </td></tr>
<tr> <td colspan=1 rowspan=1 > 9824 </td><td colspan=1 rowspan=1 > 4-Fluoroisobutyryl fentanyl ((N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) or Para-fluoroisobutyryl fentanyl) </td></tr>
<tr> <td colspan=1 rowspan=1 > 9825 </td><td colspan=1 rowspan=1 > 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide (Methoxyacetyl fentanyl) </td></tr>
<tr> <td colspan=1 rowspan=1 > 9836 </td><td colspan=1 rowspan=1 > Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide, N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide) </td></tr>
<tr> <td colspan=1 rowspan=1 > 9843 </td><td colspan=1 rowspan=1 > N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide (Tetrahydrofuranyl fentanyl) </td></tr>
<tr> <td colspan=1 rowspan=1 > 9845 </td><td colspan=1 rowspan=1 > (1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide (cyclopropyl fentanyl) </td></tr>
<tr> <td colspan=1 rowspan=1 > 7032 </td><td class="highlighted"  colspan=1 rowspan=1 > N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (MAB-CHMINACA; ADB-CHMINACA) </td></tr>
<tr> <td colspan=1 rowspan=1 > 9840 </td><td colspan=1 rowspan=1 > N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valeryl fentanyl) </td></tr>
<tr> <td colspan=1 rowspan=1 > 9823 </td><td colspan=1 rowspan=1 > N-(4-fluorophenyl)N-(1-phenethylpiperidin-4-yl)butyramide (para-fluorobutyryl fentanyl) </td></tr>
<tr> <td colspan=1 rowspan=1 > 9837 </td><td colspan=1 rowspan=1 > N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide (para-methoxybutyryl fentanyl) </td></tr>
<tr> <td colspan=1 rowspan=1 > 9826 </td><td colspan=1 rowspan=1 > N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (para-chloroisobutyryl fentanyl) </td></tr>
<tr> <td colspan=1 rowspan=1 > 9827 </td><td colspan=1 rowspan=1 > N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl fentanyl) </td></tr>
<tr> <td colspan=1 rowspan=1 > 9847 </td><td colspan=1 rowspan=1 > N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide (cyclopentyl fentanyl) </td></tr>
<tr> <td colspan=1 rowspan=1 > 9838 </td><td colspan=1 rowspan=1 > N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide (ocfentanil) </td></tr>
<tr> <td colspan=1 rowspan=1 > 9850 </td><td colspan=1 rowspan=1 > Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethers </td></tr>
</table> <br> <h3>Sentence(s)</h3>1. ADB-CHMINACA is a Schedule I drug. <br> <br><br><b>Categories:</b><br><b>Numerical:</b> Uses math skills for writing the sentence. Uses math operations (addition, subtraction, average, etc.), counting numbers, frequency of items, etc.<br> <b>Commonsense:</b> Uses commonsene knowledge about situations humans encounter in everyday life â€“ physical objects, word meanings, social or physical domains, peoples' intentions, etc.<br> <b>Temporal:</b> When concepts related to time and temporal aspects are required for writing the sentence. Duration, ordering, typical time of events, time differences between events.<br> <b>Table:</b> Writing the sentence requires knowledge from the table except: the highlighted cells, row and column headers, table titles, section titles, section texts.<br> <b>Out of Table:</b> Writing the sentence requires external knowledge that is not present in the table nor common sense. Knowledge about some specific domain comes under this category. </body></html>
